10 February 2021

Blockchain II Law: Another step forward for the digitalization of EU capital markets

A new law allowing the issue, holding and maintenance of dematerialised securities entirely on secured electronic registration systems, such as DLT or databases, managed by central account keepers, entered into force on 22 January 2021 (the “Blockchain II Law”). The Blockchain II Law enables Luxembourg and EEA investment firms and credit institutions to operate as central account keepers for non-listed debt securities.

The Luxembourg legislator marks another milestone for the use of new technologies in the issuance and circulation of transferable securities. The law of 22 January 2021 (the “Blockchain II Law”) amends the law of 6 April 2013 on dematerialised securities, as amended (the “Dematerialised Securities Law”) and the law of 5 April 1993 on the financial sector, as amended (the “Financial Sector Law”).

The Blockchain II Law brings further innovation with respect to the regulation of dematerialised securities in the Grand Duchy of Luxembourg by allowing investment firms and credit institutions to hold and manage securities issuance accounts via secured electronic registration systems such as distributed ledger technology (“DLT”) (e.g., blockchain) and databases.

Print


Press contact
Beate Dünschede
+352 271802-29
beate.duenschede@gsk-lux.com

Back

GSK Updates
  • 17.08.2022

    GSK Update: CAA Circular 22/15: What is new for the governance of insurance and reinsurance companies

    Read more
  • 10.02.2022

    GSK Update: Update of the Luxembourg Securitisation Law: Increased Flexibility and Legal Certainty

    Read more
  • 27.01.2022

    GSK Update: CSSF Guidance on Virtual Assets: New FAQ for UCI and credit institutions

    Read more
Contact person

Andreas Heinzmann, LL.M.

Partner

+352 271802-30

andreas.heinzmann@gsk-lux.com

Valerio Scollo, LL.M.

Local Partner

+352 271802-32

valerio.scollo@gsk-lux.com

Andrea Carraretto, LL.M.

Associate

+352 271802-42

andrea.carraretto@gsk-lux.com

© GSK Stockmann 2022